387068008: Terazosin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action\Alpha adrenergic receptor antagonist\Substance with alpha-1 adrenergic receptor antagonist mechanism of action (substance)\Terazosin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Terazosin	Is a	Substance with alpha-1 adrenergic receptor antagonist mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin	Has disposition	Alpha-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin	Is a	Alpha adrenergic receptor antagonist	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin	Is a	Vasodilator (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin	Is a	Autonomic agent (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing terazosin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin adverse reaction (disorder)	Causative agent (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to terazosin (finding)	Causative agent (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin 1mg+2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin (as terazosin hydrochloride) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride [see chap B for generic preps]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin 1mg tablet and 2mg tablet and 5mg tablet starter pack	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride 10mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Terazosin hydrochloride (substance)	Is a	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to terazosin (finding)	Causative agent (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin (as terazosin hydrochloride) 5 mg oral tablet	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin hydrochloride (substance)	Is modification of (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule	Has precise active ingredient	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only terazosin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin (as terazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin (as terazosin hydrochloride) 1 mg oral capsule	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Terazosin (as terazosin hydrochloride) 5 mg oral capsule	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely terazosin (as terazosin hydrochloride) 10 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Terazosin	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461246017	Terazosin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481182010	Terazosin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461246017	Terazosin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461246017	Terazosin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481182010	Terazosin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481182010	Terazosin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
376371000195119	terazosina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
844311000172112	térazosine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
844311000172112	térazosine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
376371000195119	terazosina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module